Psychedelic Health features PAREA manifesto

Psychedelic Health featured PAREA’s call for a European advisory body on psychedelics in a recent policy briefing to the European Medicines Agency (EMA), aligning with the EMA's 2023 workshop on the topic. This development responds to a letter from cross-party MEPs, including Alex Agius Saliba, Robert Biedroń, and Sara Cerdas, urging swift EU action on psychedelics. Tadeusz Hawrot, Founder and Director of PAREA, emphasizes the need for a multidisciplinary advisory body to establish standards and facilitate regulatory approval for psychedelic therapies.

Read the full article here.